Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Samuel Adjei
Kwame Nkrumah University of Science and Technology, Ghana
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
73
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial
Number of pages: 34
Posted: 08 Nov 2024
Tsiri Agbenyega
,
Anne E. Schuind
, Samuel Adjei,
Kalpana Antony
,
John J. Aponte
,
Patrick BY Buabeng
,
John D. Clemens
,
Lokman Hossain
,
Troy J. Kemp
,
Laina D. Mercer
,
Ligia A. Pinto
,
Firdausi Qadri
,
Kristen Sukraw
,
Niranjan Bhat
and
Khalequ Zaman
Agogo Malaria Research Centre, PATH, Kwame Nkrumah University of Science and Technology, Ghana, PATH, PATH, Kwame Nkrumah University of Science and Technology, Ghana, International Vaccine Institute, International Centre for Diarrheal Disease Research (ICDDR’B), Government of the United States of America - HPV Serology Laboratory, PATH, Government of the United States of America - HPV Serology Laboratory, International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Disease Division, PATH, PATH and International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Diseases Division
Downloads
73
(658,483)
View PDF
Download
Abstract:
Human papillomavirus (HPV), HPV vaccine, immunization, immunobridging, one-dose immunogenicity
Feedback